Kathryn Pohlson is the senior director of innovation and commercialization at Sanford Health. She has significant experience with early to late-stage startup companies with a focus on quality and regulatory. In collaboration with FDA, she developed a template that can be used for developing an original IDE application and has helped several institutions establish templates and infrastructure to successfully complete FDA-regulated clinical trials.

Kathryn has served as a strategic advisor and board representative for several biotech companies from product development through market launch phases. She has assisted in the development and implementation of regulatory strategies for medical devices, therapeutics, and biologics to meet the requirements of the U.S. Food and Drug Administration (FDA) and other international regulatory authorities. She also has a strong background in healthcare operations to help develop successful deployment strategies that translate to clinical implementation. Katie is active in the innovation sector and serves on the steering committee of several organizations to help foster entrepreneurship and technology development.